MelchioriLGardenghiSRivellaS.beta-Thalassemia: HiJAKing ineffective erythropoiesis and iron overload. Adv Hematol2010;
2010:938640
5.
PoggialiECassinerioEZanaboniLCappelliniMD.An update on iron chelation therapy. Blood Transfus2012;
10:411–22
6.
LekawanvijitSChattipakornN.Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity. Can J Cardiol2009;
25:213–8
7.
BartfayWJBartfayE.Iron-overload cardiomyopathy: evidence for a free radical–mediated mechanism of injury and dysfunction in a murine model. Biol Res Nurs2000;
2:49–59
8.
GaoXQianMCampianJLMarshallJZhouZRobertsAMKangYJPrabhuSDSunXFEatonJW.Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload. Free Radic Biol Med2010;
49:401–7
9.
ChenWXiaYZhaoXWangHChenWYuMLiYYeHZhangY.The critical role of astragalus polysaccharides for the improvement of PPARalpha [correction of PPRAalpha]-mediated lipotoxicity in diabetic cardiomyopathy. PLoS One2012;
7:e45541
10.
JuJChenWLaiYWangLWangHChenWJZhaoXYeHLiYZhangY.Astragalus polysaccharides improve cardiomyopathy in STZ-induced diabetic mice and heterozygous (SOD2+/−) knockout mice. Braz J Med Biol Res2017;
50:e6204
11.
LiuDChenLZhaoJCuiK.Cardioprotection activity and mechanism of astragalus polysaccharide in vivo and in vitro. Int J Biol Macromol2018;
111:947–52
12.
ZhangYKongWNChaiXQ.Compound of icariin, astragalus, and puerarin mitigates iron overload in the cerebral cortex of alzheimer's disease mice. Neural Regen Res2018;
13:731–6
13.
YangFYanGLiYHanZZhangLChenSFengCHuangQDingFYuYBiCCaiBYangL.Astragalus polysaccharide attenuated iron overload-induced dysfunction of mesenchymal stem cells via suppressing mitochondrial ROS. Cell Physiol Biochem2016;
39:1369–79
14.
van AckerFABovenEKramerKHaenenGRBastAvan der VijghWJ.Frederine, a new and promising protector against doxorubicin-induced cardiotoxicity. Clin Cancer Res2001;
7:1378–84
15.
IncharoenTThephinlapCSrichairatanakoolSChattipakornSWinichagoonPFucharoenSVadolasJChattipakornN.Heart rate variability in beta-thalassemic mice. Int J Cardiol2007;
121:203–4
16.
PacherPNagayamaTMukhopadhyayPBatkaiSKassDA.Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc2008;
3:1422–34
17.
KumfuSChattipakornSChindaKFucharoenSChattipakornN.T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice. Eur J Haematol2012;
88:535–48
18.
GrottoDSanta MariaLDBoeiraSValentiniJCharaoMFMoroAMNascimentoPCPomblumVJGarciaSC.Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection. J Pharm Biomed Anal2007;
43:619–24
19.
Siri-AngkulNChattipakornSCChattipakornN.Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients. Expert Rev Hematol2018;
11:471–9
20.
KumfuSChattipakornSSrichairatanakoolSSettakornJFucharoenSChattipakornN.T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice. Eur J Haematol2011;
86:156–66
21.
KumfuSChattipakornSCFucharoenSChattipakornN.Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice. Exp Physiol2016;
101:521–39
22.
YangBKirbySLewisJDetloffPJMaedaNSmithiesO.A mouse model for beta 0-thalassemia. Proc Natl Acad Sci USA1995;
92:11608–12
23.
ChattipakornNIncharoenTKanlopNChattipakornS.Heart rate variability in myocardial infarction and heart failure. Int J Cardiol2007;
120:289–96
24.
KardelenFTezcanGAkcurinGErtugHYesilipekA.Heart rate variability in patients with thalassemia major. Pediatr Cardiol2008;
29:935–9
25.
RutjanapromWKanlopNCharoenkwanPSittiwangkulRSrichairatanakoolSTantiworawitAPhrommintikulAChattipakornSFucharoenSChattipakornN.Heart rate variability in beta-thalassemia patients. Eur J Haematol2009;
83:483–9
26.
ThephinlapCPhisalaphongCLailerdNChattipakornNWinichagoonPVadolasJFucharoenSPorterJBSrichairatanakoolS.Reversal of cardiac iron loading and dysfunction in thalassemic mice by curcuminoids. Med Chem2011;
7:62–9
27.
ThummasornSKumfuSChattipakornSChattipakornN.Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria. Mitochondrion2011;
11:457–66
28.
WangYWuMAl-RousanRLiuHFanninJPaturiSArvapalliRKKattaAKakarlaSKRiceKMTriestWEBloughER.Iron-induced cardiac damage: role of apoptosis and deferasirox intervention. J Pharmacol Exp Ther2011;
336:56–63
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
